Peter Palese

Palese is the author of multiple book chapters and more than 500 scientific publications. He is also on the editorial board for Proceedings of the National Academy of Sciences of the United States of America (PNAS). He has been awarded multiple patents on viral vaccines and antivirals. Provided by Wikipedia
Showing 1 - 18 results of 18 for search 'Peter Palese', query time: 0.05s
Refine Results
-
1
The Long Road to a Universal Influenza Virus Vaccine by Peter Palese
Published 2020-07-01
Article -
2
Influenza virus transmission is dependent on relative humidity and temperature. by Anice C Lowen, Samira Mubareka, John Steel, Peter Palese
Published 2007-10-01
Article -
3
-
4
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses by Eduard Puente-Massaguer, Annika Beyer, Madhumathi Loganathan, Iden Sapse, Juan Manuel Carreño, Juan Manuel Carreño, Goran Bajic, Weina Sun, Peter Palese, Peter Palese, Florian Krammer, Florian Krammer, Florian Krammer
Published 2023-06-01
Article -
5
-
6
-
7
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1 by Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, Sonia Jangra, Thomas Kehrer, Ignacio Mena, Michael Schotsaert, Thomas Muster, Peter Palese, Adolfo García-Sastre
Published 2021-11-01
Article -
8
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine by Kristien Van Reeth, Anna Parys, José Carlos Mancera Gracia, Ivan Trus, Koen Chiers, Philip Meade, Sean Liu, Peter Palese, Florian Krammer, Elien Vandoorn
Published 2023-11-01
Article -
9
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model by Wen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, Shirin Strohmeier, Alicia Solórzano, Francesco Berlanda-Scorza, Bruce L. Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer, Randy A. Albrecht
Published 2021-01-01
Article -
10
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination by Teresa Aydillo, Ana S. Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D. Nair, Chiara Mariottini, Stuart C. Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Published 2022-12-01
Article -
11
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach by Irene González-Domínguez, Eduard Puente-Massaguer, Adam Abdeljawad, Tsoi Ying Lai, Yonghong Liu, Madhumathi Loganathan, Benjamin Francis, Nicholas Lemus, Victoria Dolange, Marta Boza, Stefan Slamanig, Jose Luis Martínez-Guevara, Florian Krammer, Peter Palese, Weina Sun
Published 2024-11-01
Article -
12
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nu... by Carly M. Bliss, Raffael Nachbagauer, Chiara Mariottini, Frans Cuevas, Jodi Feser, Abdi Naficy, David I. Bernstein, Jeffrey Guptill, Emmanuel B. Walter, Francesco Berlanda-Scorza, Bruce L. Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer, Lynda Coughlan
Published 2024-06-01
Article -
13
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine by Weina Sun, Stephen McCroskery, Wen-Chun Liu, Sarah R. Leist, Yonghong Liu, Randy A. Albrecht, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schäfer, Kenneth H. Dinnon, Bruce L. Innis, Adolfo García-Sastre, Florian Krammer, Ralph S. Baric, Peter Palese
Published 2020-12-01
Article -
14
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female miceResearch in context by Stefan Slamanig, Irene González-Domínguez, Lauren A. Chang, Nicholas Lemus, Tsoi Ying Lai, Jose Luis Martínez, Gagandeep Singh, Victoria Dolange, Adam Abdeljawad, Shreyas Kowdle, Moataz Noureddine, Prajakta Warang, Gagandeep Singh, Benhur Lee, Adolfo García-Sastre, Florian Krammer, Michael Schotsaert, Peter Palese, Weina Sun
Published 2024-07-01
Article -
15
Group 1 and group 2 hemagglutinin stalk antibody response according to age by Laura Sánchez-de Prada, Laura Sánchez-de Prada, Iván Sanz-Muñoz, Weina Sun, Peter Palese, Raúl Ortiz de Lejarazu, José María Eiros, José María Eiros, José María Eiros, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Teresa Aydillo, Teresa Aydillo
Published 2023-05-01
Article -
16
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity by Raveen Rathnasinghe, Lauren A. Chang, Rebecca Pearl, Sonia Jangra, Amy Aspelund, Alaura Hoag, Soner Yildiz, Ignacio Mena, Weina Sun, Madhumathi Loganathan, Nicholas Alexander Crossland, Hans P. Gertje, Anna Elise Tseng, Sadaf Aslam, Randy A. Albrecht, Peter Palese, Florian Krammer, Michael Schotsaert, Thomas Muster, Adolfo García-Sastre
Published 2024-09-01
Article -
17
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico by Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E. Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz-Stern, Yolanda López-Vidal, Alejandro E. Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino López-Macías, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard
Published 2023-05-01
Article -
18
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals by Alejandro Torres-Flores, Alejandro Torres-Flores, Luis Alberto Ontiveros-Padilla, Ruth Lizzeth Madera-Sandoval, Ruth Lizzeth Madera-Sandoval, Araceli Tepale-Segura, Julián Gajón-Martínez, Tania Rivera-Hernández, Tania Rivera-Hernández, Eduardo Antonio Ferat-Osorio, Arturo Cérbulo-Vázquez, Lourdes Andrea Arriaga-Pizano, Laura Bonifaz, Laura Bonifaz, Georgina Paz-De la Rosa, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, David Sarfati-Mizrahi, Weina Sun, Héctor Elías Chagoya-Cortés, Peter Palese, Florian Krammer, Florian Krammer, Florian Krammer, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Bernardo Lozano-Dubernard, Constantino López-Macías
Published 2024-05-01
Article